Location
Indianapolis, IN
Type
Full-time
Posted
9/24/2026
Compensation
Not listed
Job description
As a Senior Research Scientist in Analytical Development at Elanco, you will play a pivotal role in advancing the analytical and dissolution control strategies for the company's small molecule portfolio. You will be part of the Technical Development team, contributing to the drug development pipeline and ensuring compliance with global quality and regulatory standards. This position emphasizes scientific leadership and mentoring, fostering a culture of excellence within the analytical development function. Your work will directly impact the commercialization of new animal health products.
Requirements
- PhD in Analytical Chemistry, Pharmacy, Pharmaceutical Sciences, or a related field with a minimum of 5 years of experience, or M.S. with 10 years, or B.S. with 15 years of experience.
- Strong expertise in chromatographic (HPLC/UPLC), spectroscopic (UV/VIS), and dissolution method development.
- Extensive knowledge of current quality and regulatory requirements for new drug products.
- Demonstrated track record of successful interactions with regulatory agencies on analytical topics.
Responsibilities
- Develop, validate, and deliver robust analytical and dissolution methods and specifications.
- Drive the evaluation and implementation of new technologies to advance the drug development process.
- Interpret complex scientific data and effectively report and present technical results.
- Author and support the generation of international registration documents.
- Mentor and coach emerging technical talent within the analytical development function.
- Ensure all activities comply with internal and external quality standards and guidelines.
Benefits
- Employees at Elanco are often offered competitive compensation with annual bonus and equity eligibility, retirement plans (including a U.S. 401(k)), and comprehensive health coverage—medical, dental, vision, company-paid life and disability—and even pet insurance. Time-off and flexibility typically include generous PTO, U.S. mid-year and year-end paid shutdown weeks, parental leave, and flexible/remote work options. Employees also benefit from strong development programs (onboarding, course libraries, mentorship, nine ERGs, and tiered leadership programs) that support both professional growth and community involvement.
H-1B filing history
Public USCIS petition and DOL LCA counts · latest USCIS FY2026, LCA FY2026
Combined across 2 filing entities: Elanco Us Inc, Elanco Animal Health Inc
As of Aug 23, 2026
Initial approvals
4
FY2026
Approval rate
100.0%
FY2026
LCA certified
12
FY2026
Entry-level share
0.0%
FY2026
Initial approvals YoY
+3%
Trend
LCA certified YoY
-25%
Trend
Initial approvals by fiscal year
Approval rate by fiscal year
Continuing vs initial approvals
LCA certified positions by quarter
LCA certified positions by fiscal year
Based on public USCIS and DOL filings; not a sponsorship guarantee.
Is this posting expired or inaccurate?
